
Ayoush Ferma Biotech Private Limited
Founded in March 2025 and headquartered in Telangana, India.
Founded in March 2025 and headquartered in Telangana, India.
Ayoush Ferma Biotech Private Limited (AFBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 March 2025 ( one month 9 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Laxmi Aerra and Karri Swetha serve as directors at the Company.
Rangareddy, Telangana, India
+91-XXXXXXXXXX
U72100TS2025PTC194975
194975
Private Limited Indian Non-Government Company
02 Mar 2025
-
-
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Laxmi Aerra ![]() | Director | 02-Mar-2025 | Current |
Karri Swetha | Director | 02-Mar-2025 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Ayoush Ferma Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Laxmi Aerra is a mutual person
Laxmi Aerra is a mutual person
Laxmi Aerra is a mutual person
Laxmi Aerra is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ayoush Ferma Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ayoush Ferma Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayoush Ferma Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Laxmi Naresh Reddy Aerra was appointed as a Director was appointed as a Director on 02 Mar 2025 & has been associated with this company since 1 month 9 days .
Karri Swetha was appointed as a Director was appointed as a Director on 02 Mar 2025 & has been associated with this company since 1 month 9 days .
Ayoush Ferma Biotech Private Limited was registered on 02 Mar 2025 with Roc Hyderabad & aged 1 month 9 days as per MCA records.
Ayoush Ferma Biotech Private Limited was incorporated on 02 Mar 2025.
The authorized share capital of Ayoush Ferma Biotech Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 2 directors are associated with Ayoush Ferma Biotech Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Ayoush Ferma Biotech Private Limited is Plot No: 28 29, Ida Nacharam India, Uppal, Telangana, 500076.
The corporate identification number (CIN) of Ayoush Ferma Biotech Private Limited is U72100TS2025PTC194975 and the company number is 194975 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.